# Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

> **NCT04561089** · — · COMPLETED · sponsor: **Illumina, Inc.** · enrollment: 763 (actual)

## Conditions studied

- SARS-CoV-2

## Interventions

- **DIAGNOSTIC_TEST:** COVIDSeq Test

## Key facts

- **NCT ID:** NCT04561089
- **Lead sponsor:** Illumina, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-13
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 763 (ACTUAL)
- **Last updated:** 2022-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04561089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04561089, "Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04561089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*